Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 1.53 g/t Au over 191.3m in infill drilling at Golden Summit (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News ProKidney Corporation PROK

Healthcare Biotechnology
ProKidney Corp., a clinical-stage biotechnology company, develops a cell therapy platform for the treatment of multiple chronic kidney diseases in the United States. Its lead product candidate, rilparencel, includes autologous selected renal cells (SRC) in Phase 3 and Phase 2 clinical studies in subjects with moderate to severe chronic kidney disease and diabetes. The company also develops a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:PROK)

ProKidney Reports Third Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

GlobeNewswire November 10, 2025

ProKidney Presents Full Results from the Phase 2 REGEN-007 Trial of Rilparencel at the American Society of Nephrology Kidney Week 2025

GlobeNewswire November 6, 2025

ProKidney to Participate in Two Upcoming Conferences: Guggenheim Healthcare Innovation Conference and the Jefferies Global Healthcare Conference

GlobeNewswire October 29, 2025

ProKidney Announces Two Abstracts Selected for Presentation at the American Society of Nephrology's Kidney Week 2025

GlobeNewswire October 20, 2025

ProKidney to Participate in Two Upcoming Conferences: the Citi Biopharma Back to School Conference and the Morgan Stanley Global Healthcare Conference

GlobeNewswire August 27, 2025

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

GlobeNewswire August 12, 2025

ProKidney Announces Alignment with the FDA on the Accelerated Approval Pathway for Rilparencel

GlobeNewswire July 15, 2025

ProKidney to Participate in the H.C. Wainwright 4th Annual Kidney Virtual Conference

GlobeNewswire July 9, 2025

ProKidney Reports Statistically and Clinically Significant Topline Results for the Phase 2 REGEN-007 Trial Evaluating Rilparencel in Patients with Chronic Kidney Disease and Diabetes

GlobeNewswire July 8, 2025
View More News ››

Opinion & Analysis (NDAQ:PROK)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:PROK)

Sell buddy sell.

It is signalling time for me to get out of this stock at these prices per share,so good luck to all of you guys out there,and it's...
coolfooldumbguy - July 8, 2025

PROK.....LMFBO !!!

LFG !!!!
Iseneschal - July 8, 2025

PROK....and now for the Gap fills below ; )

Rug pull time ? $2.35 down to $1.79 Last at $2.62......Wait for it ; )
Iseneschal - July 8, 2025

PROK....N.H.O.D $2.84

Best Short of the Day !!!!!
Iseneschal - July 8, 2025

PROK....Halt and rallying

$2.50
Iseneschal - July 8, 2025

PROK....has to hold $1.78

See what happens here....now at $2.01
Iseneschal - July 8, 2025
View more Bullboard ››

Coelacanth Energy Inc.

Coelacanth Energy Inc.

Coelacanth Energy Inc., an oil and natural gas company, engages in the acquisition, development, exploration, and production ...
View More »